1,516 articles
John Deanfield
John Deanfield is a British cardiologist, Professor of Cardiology at University College London and director of NICOR, known for landmark studies on smoking, endothelial function, and cardiovascular prevention.
John Dimarco
John P. DiMarco is an American cardiologist and cardiac electrophysiologist at the University of Virginia, known for work on adenosine, ventricular tachycardia mechanisms, and implantable defibrillators.
John E. Gerich
John E. Gerich, known as Jack, is an American endocrinologist and Professor Emeritus at the University of Rochester, known for a 1973 Science paper on glucagon deficiency in type 1 diabetes.
John F. Keaney
John F. Keaney is an American cardiologist who leads Cardiovascular Medicine at Brigham and Women's Hospital and studies how blood vessels resist injury from cholesterol, blood pressure, and diabetes.
John G. Haddad
John G. Haddad (1937–1997) was an American endocrinologist at the University of Pennsylvania who developed the first reliable blood test for vitamin D and led its endocrinology division.
John G. Webb
John G. Webb is a Canadian interventional cardiologist at the University of British Columbia and St Paul's Hospital, Vancouver, who pioneered transcatheter aortic valve implantation and trained valve groups in over 25 countries.
John G.F. Cleland
John G.F. Cleland, known as John Cleland, is a British cardiologist and Emeritus Professor at the University of Glasgow, known for leading the CARE-HF trial of cardiac resynchronization therapy.
John H. Alexander
John H. Alexander is an American cardiologist, Professor of Medicine at Duke University, and Director of Cardiovascular Research at the Duke Clinical Research Institute, known for the ARISTOTLE and AUGUSTUS apixaban trials.
John J. Gallagher
John J. Gallagher (John Joseph Gallagher, 1943–2020) was an American cardiac electrophysiologist who pioneered surgical and catheter ablation, led Duke's electrophysiology program, and shaped the classification of preexcitation syndromes.
John J.P. Kastelein
John J.P. Kastelein, also known as J.J.P. Kastelein, is a Dutch vascular medicine specialist and lipidologist, Emeritus Professor at Amsterdam UMC, known for familial hypercholesterolemia research.
John J.V. McMurray
John J.V. McMurray, known as John McMurray, is a British cardiologist and Professor of Medical Cardiology at the University of Glasgow, known for the PARADIGM-HF and DAPA-HF heart failure trials.
John L. Sapp
John L. Sapp is a Canadian cardiac electrophysiologist and professor at Dalhousie University in Halifax who led the VANISH and VANISH2 trials establishing catheter ablation for ventricular tachycardia.
John M. Lachin
John M. Lachin is an American biostatistician at George Washington University who, from 1982 to 2020, led the DCCT and EDIC clinical trials that transformed type 1 diabetes treatment.
John McMichael
Sir John McMichael (1904–1993) was a British cardiologist, professor of medicine at Hammersmith from 1946 to 1966, who introduced cardiac catheterisation into British practice and overturned prevailing views of heart failure.
John O. Parker
John O. Parker, known as Jack Parker, was a Canadian cardiologist at Queen's University who pioneered coronary angiography in Canada and whose nitrate tolerance studies reshaped angina treatment.
John P. Bilezikian
John P. Bilezikian is an American endocrinologist at Columbia University specializing in metabolic bone disease, known for long-term hyperparathyroidism research and international guidelines on osteoporosis and parathyroid disorders.
John P. Cooke
John P. Cooke is an American physician-scientist in cardiovascular medicine and vascular biology, a Stanford professor emeritus who led cardiovascular research at Houston Methodist from 2013.
John P. Peters
John Punnett Peters (1887–1955) was an American clinical chemist at Yale whose Quantitative Clinical Chemistry with Donald Van Slyke made clinical chemistry a quantitative discipline.
John R. Teerlink
John R. Teerlink is an American cardiologist and clinical trialist who directs heart failure and echocardiography at the San Francisco VA Medical Center and led the GALACTIC-HF trial of omecamtiv mecarbil.
John Robert Evans
John Robert Evans was a Canadian cardiologist and researcher, founding dean of McMaster University's medical school and president of the University of Toronto from 1972 to 1978.
John S. Floras
John S. Floras, also known as John Floras, is a Canadian cardiologist and University of Toronto professor known for research on the autonomic nervous system in heart failure.
John Speakman
John Speakman is a British physiologist at the University of Aberdeen and a professor at the Chinese Academy of Sciences, known for research on energy expenditure, obesity, and aging.
John T. Fallon
John T. Fallon is an American cardiovascular pathologist, trained at Albany Medical College and Harvard, known for the 1987 myocarditis classification behind the Dallas criteria and for endomyocardial biopsy consensus standards.
John T. Potts
John T. Potts Jr., born 1932, is an American endocrinologist who established the modern understanding of parathyroid hormone and calcium metabolism at NIH and Massachusetts General Hospital.
John T. Shepherd
John T. Shepherd (1919–2011) was a Northern Ireland-born cardiovascular physiologist at the Mayo Clinic and president of the American Heart Association from 1975 to 1976.
John W. Erdman Jr.
John W. Erdman Jr. is an American nutrition scientist and emeritus professor at the University of Illinois Urbana-Champaign, known for research on soy protein, carotenoids, and Dietary Reference Intakes.
John W. Funder
John W. Funder, born 1940 in Adelaide, is an Australian physician-scientist known for research on aldosterone and mineralocorticoid receptors in hypertension and heart failure, and chaired the 2008 Endocrine Society primary aldosteronism guidelines.
John W. McEvoy
John W. McEvoy, known as Bill McEvoy, is an Irish preventive cardiologist who is Established Professor of Preventive Cardiology at the University of Galway and chaired the 2024 ESC hypertension guidelines.
John Wahren
John Wahren, born 1937 in Uppsala, is a Swedish clinical physiologist and professor emeritus at Karolinska Institutet, known for exercise fuel metabolism research and later C-peptide replacement therapy in diabetes.
John Wilding
John P.H. Wilding is a British physician-scientist and Professor of Medicine at the University of Liverpool, known for leading large trials of GLP-1 obesity drugs, including semaglutide STEP 1.